Below is a list and status of Biosimilar Inter
Partes Reviews (IPRs). For additional comments, see these previous posts:
http://biopharmapatent.blogspot.com/2016/12/herceptin-immunoconjugate-ipr-kadcyla.html
[HERCEPTIN IMMUNOCONJUGATE IPR]
http://biopharmapatent.blogspot.com/2016/12/hospira-has-filed-petition-for-inter.html
[HERCEPTIN PROTEIN PURIFICATION IPR]
http://biopharmapatent.blogspot.com/2016/11/mylans-herceptin-ipr-biosimilar-inter.html
[HERCEPTIN HUMANIZATION IPR]
http://biopharmapatent.blogspot.com/2016/11/another-humira-formulation-patent.html
[HUMIRA FORMULATION IPR]
http://biopharmapatent.blogspot.com/2016/09/abbvies-humira-patent-portfolio.html
[HUMIRA PATENT PORTFOLIO]
http://biopharmapatent.blogspot.com/2016/09/biosimilar-ipr-inter-partes-review.html
[BIOSIMILAR IPR CONSTRUED CLAIM TERM GLOSSARY]
http://biopharmapatent.blogspot.com/2016/09/institution-of-inter-partes-reviews-ipr.html
[ANALYSIS OF BISOLIMAR IPR PETITIONS AND REASONS FOR THEIR INSTITUTION/DENIAL]
Filing Date
|
Institution Decision Date
|
Patent Number
|
Petitioner
|
Patent Owner
|
Status
|
|
IPR2016-00408
|
12/29/2015
|
07/07/2016
|
8889135
|
Boehringer Ingelheim GmbH
|
AbbVie Biotechnology Ltd.
Humira
|
Trial Instituted
|
IPR2016-00409
|
12/29/2015
|
07/07/2016
|
8889135
|
Boehringer Ingelheim GmbH
|
AbbVie Biotechnology Ltd.
Humira
|
Trial Instituted
|
IPR2016-00172
|
11/09/2015
|
05/17/2016
|
8889135
|
Coherus BioSciences Inc.
|
AbbVie Biotechnology Ltd.
Humira
|
Trial Instituted
|
IPR2015-01514
|
06/26/2015
|
01/14/2016
|
8916157
|
Amgen Inc
|
AbbVie Biotechnology Ltd.
Humira
|
Terminated
|
IPR2015-01517
|
06/26/2015
|
01/14/2016
|
8916158
|
Amgen Inc
|
AbbVie Biotechnology Ltd.
Humira
|
Terminated
|
IPR2016-00188
|
12/07/2015
|
06/13/2016
|
9017680
|
Coherus BioSciences Inc.
|
AbbVie Biotechnology Ltd.
Humira
|
Trial Instituted
|
IPR2016-00189
|
12/07/2015
|
06/13/2016
|
9073987
|
Coherus BioSciences Inc.
|
AbbVie Biotechnology Ltd.
Humira
|
Trial Instituted
|
IPR2016-01018
|
05/09/2016
|
9114166
|
Coherus BioSciences Inc.
|
AbbVie Biotechnology Ltd.
Humira
|
Terminated
|
|
IPR2016-01542
|
08/05/2016
|
8952138
|
Apotex Inc.
|
Amgen Inc.
Neulasta
|
Pending
|
|
IPR2015-00418
|
12/15/2014
|
07/13/2015
|
8329172
|
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Biogen Inc.
Rituxan
|
Terminated
|
IPR2016-00915
|
04/18/2016
|
8349321
|
Swiss Pharma International AG
|
Biogen MA Inc.
Tysabri
|
Trial Denied
|
|
IPR2016-00912
|
04/18/2016
|
8815236
|
Swiss Pharma International AG
|
Biogen MA Inc.
Tysabri
|
Trial Denied
|
|
IPR2016-00916
|
04/18/2016
|
8900577
|
Swiss Pharma International AG
|
Biogen MA Inc.
Tysabri
|
Trial Denied
|
|
IPR2015-01537
|
07/02/2015
|
01/15/2016
|
8476239
|
Momenta Pharmaceuticals, Inc.
|
Bristol-Myers Squibb Company
Orencia
|
Final Written Decision
|
IPR2016-00460
|
01/15/2016
|
06/08/2016
|
6331415
|
Genzyme Corporation
|
Genentech, Inc.
Cabilly
|
Terminated
|
IPR2016-00710
|
03/03/2016
|
09/08/2016
|
6331415
|
Mylan Pharmaceuticals Inc.
|
Genentech, Inc.
Cabilly
|
Trial Instituted
|
IPR2016-01373
|
07/07/2016
|
6331415
|
Merck Sharp & Dohme Corp.
|
Genentech, Inc.
Cabilly
|
Pending
|
|
IPR2016-00383
|
12/30/2015
|
06/23/2016
|
6331415
|
GENZYME CORPORATION
|
Genentech, Inc.
Cabilly
|
Terminated
|
IPR2015-01624
|
07/27/2015
|
02/05/2016
|
6331415
|
Sanofi-Aventis U.S. LLC
|
Genentech, Inc.
Cabilly
|
Terminated
|
IPR2016-01693
|
08/30/2016
|
6407213
|
Mylan Pharmaceuticals Inc.
|
Genentech, Inc.
Herceptin
|
Pending
|
|
IPR2016-01694
|
08/30/2016
|
6407213
|
Mylan Pharmaceuticals Inc.
|
Genentech, Inc.
Herceptin
|
Pending
|
|
IPR2016-01608
|
08/16/2016
|
6716602
|
bioeq IP AG
|
Genentech, Inc.
Protein Production
|
Pending
|
|
IPR2016-01614
|
08/15/2016
|
7820161
|
Celltrion, Inc.
|
Genentech, Inc.
Rituxan
|
Pending
|
|
IPR2015-00415
|
12/15/2014
|
07/17/2015
|
7820161
|
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Genentech, Inc.
Rituxan
|
Terminated
|
IPR2015-01744
|
08/17/2015
|
10/06/2015
|
7820161
|
Celltrion, Inc.
|
Genentech, Inc.
Rituxan
|
Trial Denied
|
IPR2015-01733
|
08/14/2015
|
10/06/2015
|
7976838
|
Celltrion, Inc.
|
Genentech, Inc.
Rituxan
|
Trial Denied
|
IPR2015-00417
|
12/15/2014
|
07/14/2015
|
7976838
|
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Genentech, Inc.
Rituxan
|
Terminated
|
IPR2016-01667
|
08/24/2016
|
7976838
|
Celltrion Inc.
|
Genentech, Inc.
Rituxan
|
Pending
|
|
IPR2016-01771
|
09/09/2016
|
7622115
|
Hospira, Inc.
|
Genentech, Inc.
Avastin
|
Pending
|
|
IPR2016-01837
|
09/16/2016
|
7807799
|
Hospira, Inc.
|
Genentech, Inc.
Herceptin
|
Pending
|
|
IPR2017-00047
|
10/11/2016
|
01/03/2017
|
6331415
|
Merck Sharp & Dohme Corp.
|
Genentech, Inc.
Cabilly
|
Terminated
|
IPR2015-01792
|
08/22/2015
|
03/11/2016
|
8163522
|
Coalition for Affordable Drugs V LLC
|
Hoffmann-La Roche Inc.
Enbrel
|
Terminated
|
IPR2014-00842
|
05/29/2014
|
12/09/2014
|
7575748
|
Phigenix, Inc.
|
ImmunoGen, Inc.
Kadcyla
|
Terminated
|
IPR2014-00676
|
04/22/2014
|
10/29/2014
|
8337856
|
Phigenix, Inc.
|
ImmunoGen, Inc.
Kadcyla
|
Final Written Decision
|
IPR2013-00365
|
06/19/2013
|
10/24/2013
|
6747002
|
Hospira, Inc.
|
Janssen Pharmaceuticals, Inc.
|
Trial Denied
|
IPR2015-00990
|
04/01/2015
|
10/23/2015
|
7056886
|
Coalition for Affordable Drugs II LLC
|
NPS Pharmaceuticals, Inc.
|
Final Written Decision
|
IPR2015-01093
|
04/23/2015
|
10/23/2015
|
7056886
|
Coalition for Affordable Drugs II, LLC
|
NPS Pharmaceuticals, Inc.
|
Final Written Decision
|
IPR2016-00258
|
11/25/2015
|
05/25/2016
|
9051556
|
Green Cross Corporation
|
Shire Human Genetic Therapies, Inc.
|
Trial Instituted
|
No comments:
Post a Comment